PACU Pyxis Overrides

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

4 posts / 0 new
Log in or register to post comments
Last post
Fri, 07/12/2024 - 12:05
#1
Amy Kauffman
Amy Kauffman's picture
Offline
Last seen: 3 weeks 3 days ago
Joined: 12/31/2021 - 13:02
PACU Pyxis Overrides

Greetings -

At my institution, we are currently experiencing an elevated rate of overrides from our PACU units. My PACU team informs me that overrides are unavoidable as they titrate IV analgesics based on patient response. For those overseeing this type of data, I seek your guidance. Should PACU areas be excluded from override data analysis? How can we manage the removal of narcotic analgesics when dosage requirements are variable and difficult to predict?

Thank you for your insights and recommendations.

Top